Article Details
Retrieved on: 2024-10-17 13:30:40
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses using chitosan-based nanoparticles for intranasal delivery of tuberculosis drugs to the brain, bypassing the blood-brain barrier, thus enhancing treatment effectiveness for Central Nervous System Tuberculosis. This relates to the key concept by emphasizing chitosan's role in drug delivery to the brain.
Article found on: medibulletin.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here